{"transactions":[{"id":686,"issuer":{"id":613,"kind":"organization","name":"Olema Pharmaceuticals, Inc.","symbol":"OLMA"},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-02T20:30:29.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on August 11, 2027 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":650000,"derivative":{"exercise_price":10.56,"expiration_date":"2036-08-31","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001871145-26-000006","document":"form4-09022026_040901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1871145/000187114526000006/form4-09022026_040901.xml","form_type":"4"}},{"id":830817,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common  Stock","published_at":"2026-03-23T19:49:52.000Z","date":"2026-03-20","kind":"other","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for estate planning purposes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held in the name of the O'Byrne Family Trust, of which the Reporting Person and his spouse are Trustees."}],"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001628280-26-020480","document":"wk-form4_1774295389.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026020480/wk-form4_1774295389.xml","form_type":"4"}},{"id":830816,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common  Stock","published_at":"2026-03-23T19:49:52.000Z","date":"2026-03-20","kind":"other","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transfer without consideration for estate planning purposes."}],"balance_after":160115,"source":{"system":"sec-edgar","filing":"0001628280-26-020480","document":"wk-form4_1774295389.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026020480/wk-form4_1774295389.xml","form_type":"4"}},{"id":879705,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common  Stock","published_at":"2026-02-26T21:55:39.000Z","date":"2026-02-24","kind":"sale","planned":true,"acquired":false,"shares":1634,"price":9.5326,"value":15576.2684,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents an automatic and mandatory sale of shares under a  Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of restricted stock units. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":162615,"source":{"system":"sec-edgar","filing":"0001628280-26-012395","document":"wk-form4_1772142937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026012395/wk-form4_1772142937.xml","form_type":"4"}},{"id":885008,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock  Option  (Right  to Buy)","published_at":"2026-02-25T00:12:25.000Z","date":"2026-02-22","kind":"grant","planned":true,"acquired":true,"shares":110000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the stock option will vest and become exercisable on February 22, 2027, and the remaining shares will vest in 36 equal monthly installments thereafter."}],"balance_after":110000,"derivative":{"exercise_price":7.56,"expiration_date":"2036-02-21","underlying":"Common  Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001628280-26-011330","document":"wk-form4_1771978342.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026011330/wk-form4_1771978342.xml","form_type":"4"}},{"id":885007,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common  Stock","published_at":"2026-02-25T00:12:25.000Z","date":"2026-02-23","kind":"sale","planned":true,"acquired":false,"shares":2089,"price":7.4528,"value":15568.8992,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents an automatic and mandatory sale of shares under a  Rule 10b5-1 arrangement to satisfy the Issuer's tax withholding obligations in connection with the vesting of RSUs. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":164249,"source":{"system":"sec-edgar","filing":"0001628280-26-011330","document":"wk-form4_1771978342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026011330/wk-form4_1771978342.xml","form_type":"4"}},{"id":885006,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common  Stock","published_at":"2026-02-25T00:12:25.000Z","date":"2026-02-22","kind":"grant","planned":true,"acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 637 shares of common stock acquired by the Reporting Person on November 28, 2025, pursuant to an employee stock purchase program."}],"balance_after":166338,"source":{"system":"sec-edgar","filing":"0001628280-26-011330","document":"wk-form4_1771978342.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026011330/wk-form4_1771978342.xml","form_type":"4"}},{"id":995807,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common  Stock","published_at":"2025-11-18T19:47:11.000Z","date":"2025-11-17","kind":"sale","planned":true,"acquired":false,"shares":6799,"price":5.557,"value":37782.043,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 shares of common stock acquired by the Reporting Person on May 30, 2025 pursuant to an employee stock purchase program."}],"balance_after":110701,"source":{"system":"sec-edgar","filing":"0001628280-25-052841","document":"wk-form4_1763495228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025052841/wk-form4_1763495228.xml","form_type":"4"}},{"id":1246313,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock  Option  (Right  to Buy)","published_at":"2025-02-25T20:41:04.000Z","date":"2025-02-22","kind":"grant","planned":true,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":80000,"derivative":{"exercise_price":9.57,"expiration_date":"2035-02-21","underlying":"Common  Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001628280-25-007703","document":"wk-form4_1740516057.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025007703/wk-form4_1740516057.xml","form_type":"4"}},{"id":1246312,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common  Stock","published_at":"2025-02-25T20:41:04.000Z","date":"2025-02-22","kind":"grant","planned":true,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":115000,"source":{"system":"sec-edgar","filing":"0001628280-25-007703","document":"wk-form4_1740516057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828025007703/wk-form4_1740516057.xml","form_type":"4"}},{"id":1361805,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Stock  Option  (Right  to Buy)","published_at":"2024-11-18T18:36:12.000Z","date":"2024-11-15","kind":"grant","planned":true,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the stock option vest and become exercisable on November 15, 2025, and the remaining shares vest in 36 equal monthly installments thereafter."}],"balance_after":150000,"derivative":{"exercise_price":8.64,"expiration_date":"2034-11-14","underlying":"Common  Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001628280-24-048230","document":"wk-form4_1731954966.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024048230/wk-form4_1731954966.xml","form_type":"4"}},{"id":1361804,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & Chief Financial Officer"}}],"security":"Common  Stock","published_at":"2024-11-18T18:36:12.000Z","date":"2024-11-15","kind":"grant","planned":true,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F1","text":"Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001628280-24-048230","document":"wk-form4_1731954966.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828024048230/wk-form4_1731954966.xml","form_type":"4"}},{"id":1624592,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase Common Stock","published_at":"2024-02-22T22:28:33.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":153000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the options will vest upon the one-year anniversary of the grant date, February 20, 2025, and 1/48th will vest monthly thereafter over the 36-month period following the one-year cliff, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":153000,"derivative":{"exercise_price":6.81,"expiration_date":"2034-02-19","underlying":"Common Stock","underlying_shares":153000},"source":{"system":"sec-edgar","filing":"0001628280-24-006433","document":"wk-form4_1708640897.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000162828024006433/wk-form4_1708640897.xml","form_type":"4"}},{"id":1624591,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-22T22:28:33.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This reflects restricted stock units (\"RSUs\") that vest in four equal annual installments beginning on February 20, 2025, subject to the reporting person's continued services to the Issuer through the applicable vesting dates. The RSUs will be settled in stock within 30 days after each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,888 shares purchased pursuant to the Issuer's 2021 Employee Stock Purchase Plan on February 15, 2022 for $9.85 per share."}],"balance_after":59224,"source":{"system":"sec-edgar","filing":"0001628280-24-006433","document":"wk-form4_1708640897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000162828024006433/wk-form4_1708640897.xml","form_type":"4"}},{"id":1995273,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase Common Stock","published_at":"2023-02-23T21:47:32.000Z","date":"2023-02-21","kind":"grant","acquired":true,"shares":131000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on February 21, 2027, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":131000,"derivative":{"exercise_price":6.12,"expiration_date":"2033-02-20","underlying":"Common Stock","underlying_shares":131000},"source":{"system":"sec-edgar","filing":"0001619856-23-000017","document":"wf-form4_167718882178453.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000161985623000017/wf-form4_167718882178453.xml","form_type":"4"}},{"id":2407849,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase Common Stock","published_at":"2022-02-09T00:27:09.000Z","date":"2022-02-08","kind":"exercise","acquired":false,"shares":24336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4th of the shares subject to this option vested on February 8, 2022 and an additional 1/48th of the aggregate number of shares subject to the option will vest on the corresponding day of each month thereafter until the option is fully vested on February 8, 2025, subject to the reporting person's continued services to the Issuer through the applicable vesting dates."}],"balance_after":412865,"derivative":{"exercise_price":4.11,"expiration_date":"2031-03-29","underlying":"Common Stock","underlying_shares":24336},"source":{"system":"sec-edgar","filing":"0001209191-22-007860","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919122007860/doc4.xml","form_type":"4"}},{"id":2407848,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-09T00:27:09.000Z","date":"2022-02-08","kind":"exercise","acquired":true,"shares":24336,"price":4.11,"value":100020.96,"ownership":{"direct":true},"balance_after":24336,"source":{"system":"sec-edgar","filing":"0001209191-22-007860","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919122007860/doc4.xml","form_type":"4"}},{"id":2462006,"issuer":{"id":6445,"kind":"organization","name":"Caribou Biosciences, Inc."},"owners":[{"id":614,"kind":"person","name":"O'Byrne Jason","position":1,"cik":"0001871145","reported_name":"O'Byrne Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option to purchase Common Stock","published_at":"2021-12-21T22:35:30.000Z","date":"2021-12-20","kind":"grant","acquired":true,"shares":147000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option will vest in equal monthly installments starting on the first monthly anniversary of the grant date until the option is fully vested on December 20, 2025, subject to the reporting person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":147000,"derivative":{"exercise_price":15.16,"expiration_date":"2031-12-19","underlying":"Common Stock","underlying_shares":147000},"source":{"system":"sec-edgar","filing":"0001209191-21-070819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1619856/000120919121070819/doc4.xml","form_type":"4"}}]}